|
FR580494A
(fr)
|
1923-07-10 |
1924-11-07 |
Const Metalliques Schiltigheim |
Procédé d'établissement des buses d'aération ou autres tuyaux
|
|
US2837464A
(en)
*
|
1955-01-11 |
1958-06-03 |
Schering Corp |
Process for production of dienes by corynebacteria
|
|
DE1059906B
(de)
|
1954-10-05 |
1959-06-25 |
Scherico Ltd |
Verfahren zur Herstellung von 1, 4-Pregnadienen
|
|
US3067197A
(en)
|
1961-04-26 |
1962-12-04 |
Pfizer & Co C |
11-oxygenated 6alpha-fluoro-16-methylene-delta-pregnenes and derivatives
|
|
GB1047518A
(en)
*
|
1963-06-11 |
1966-11-02 |
Glaxo Lab Ltd |
17ª-monoesters of 11,17,21-trihydroxy steroid compounds
|
|
GB1159490A
(en)
*
|
1966-02-09 |
1969-07-23 |
Boots Pure Drug Co Ltd |
Improvements in Acylated Steroids
|
|
US3639434A
(en)
|
1967-02-02 |
1972-02-01 |
Boots Pure Drug Co Ltd |
17-acyloxysteroids and their manufacture
|
|
IT1061787B
(it)
|
1967-03-01 |
1983-04-30 |
Vismara Francesco Spa |
Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
|
|
GB1227992A
(enExample)
*
|
1968-01-23 |
1971-04-15 |
Koninklijke Gist Spiritus |
|
|
US3557694A
(en)
*
|
1969-04-21 |
1971-01-26 |
Burroughs Corp |
Print head latching mechanism
|
|
IT1034011B
(it)
*
|
1969-06-26 |
1979-09-10 |
Vister Vismara Terapeutici S P |
Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
|
|
GB1384372A
(en)
|
1971-01-20 |
1975-02-19 |
Glaxo Lab Ltd |
Dereivatives of 17alpha-hydroxyandrost-4-ene-17beta-carboxylic acids
|
|
US3828080A
(en)
|
1972-01-20 |
1974-08-06 |
Glaxo Lab Ltd |
Androstane-17beta-carboxylic acids and processes for the preparation thereof
|
|
US3989686A
(en)
|
1972-06-15 |
1976-11-02 |
Glaxo Laboratories Limited |
Anaesthetic steroids of the androstane series and process for preparing same
|
|
GB1438940A
(en)
|
1972-07-19 |
1976-06-09 |
Glaxo Lab Ltd |
17beta-haloalkoxycarbonyl-17alpha-oxysteroids
|
|
GB1440063A
(en)
*
|
1972-08-11 |
1976-06-23 |
Glaxo Lab Ltd |
17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids
|
|
US3881894A
(en)
*
|
1972-10-05 |
1975-05-06 |
George R Onufer |
Vapor emission control system and method
|
|
DE2336693A1
(de)
|
1973-07-19 |
1975-02-06 |
Nassheuer Ind Ofenbau Jean |
Strahlheizrohr
|
|
US4093721A
(en)
|
1974-08-30 |
1978-06-06 |
Glaxo Laboratories Limited |
Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof
|
|
GB1517278A
(en)
|
1974-08-30 |
1978-07-12 |
Glaxo Lab Ltd |
Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates
|
|
US3969686A
(en)
*
|
1975-03-26 |
1976-07-13 |
Xerox Corporation |
Beam collimation using multiple coupled elements
|
|
YU54476A
(en)
*
|
1975-03-31 |
1982-05-31 |
Taisho Pharmaceutical Co Ltd |
Process for obtaining 17-ester 21-halo-pregnane
|
|
DE2538569A1
(de)
|
1975-08-29 |
1977-03-03 |
Siemens Ag |
Verfahren zur metallisierung von duroplasten
|
|
CH628355A5
(de)
|
1976-02-24 |
1982-02-26 |
Ciba Geigy Ag |
Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze.
|
|
US4221787A
(en)
*
|
1978-03-28 |
1980-09-09 |
Interx Research Corporation |
Esteramide prodrugs of anti-inflammatory corticosteroids
|
|
US4188385A
(en)
|
1978-04-05 |
1980-02-12 |
Syntex (U.S.A.) Inc. |
Thioetianic acid derivatives
|
|
US4198403A
(en)
|
1978-04-05 |
1980-04-15 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes
|
|
US4263289A
(en)
|
1978-04-05 |
1981-04-21 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4187301A
(en)
|
1978-04-05 |
1980-02-05 |
Syntex (U.S.A.) Inc. |
17 Beta-thiocarboxylic acid esters of 6 alpha, 6 beta-difluoro-3-oxoandrost-4-enes
|
|
US4261984A
(en)
|
1978-04-05 |
1981-04-14 |
Syntex (U.S.A.) Inc. |
17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
|
|
DE2817988A1
(de)
*
|
1978-04-25 |
1979-11-08 |
Hoechst Ag |
Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
|
|
US4310466A
(en)
|
1979-08-31 |
1982-01-12 |
Syntex (U.S.A.) Inc. |
Thio etianic acid derivatives
|
|
US4267173A
(en)
|
1979-11-05 |
1981-05-12 |
Schering Corporation |
Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
|
|
US4377389A
(en)
|
1979-12-12 |
1983-03-22 |
Foster Grant Corporation |
Dip dyeing of plastic articles and the dye bath composition thereof
|
|
CY1291A
(en)
|
1980-02-15 |
1985-10-18 |
Glaxo Group Ltd |
Androstane 17 beta carbothioates
|
|
CA1201114A
(en)
|
1980-02-15 |
1986-02-25 |
Gordon H. Phillipps |
Androstane carbothioates
|
|
US4996335A
(en)
|
1980-07-10 |
1991-02-26 |
Nicholas S. Bodor |
Soft steroids having anti-inflammatory activity
|
|
ZA814440B
(en)
|
1980-07-10 |
1982-10-27 |
Otsuka Pharma Co Ltd |
Soft steroids having anti-inflammatory activity
|
|
SE449106B
(sv)
|
1980-07-10 |
1987-04-06 |
Otsuka Pharma Co Ltd |
Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
|
|
US4710495A
(en)
|
1980-07-10 |
1987-12-01 |
Otsuka Pharmaceutical Co., Ltd. |
Soft steroids having anti-inflammatory activity
|
|
DE3260474D1
(en)
|
1981-02-02 |
1984-09-06 |
Schering Corp |
Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
|
|
ZW6584A1
(en)
|
1983-04-18 |
1985-04-17 |
Glaxo Group Ltd |
Phenethanolamine derivatives
|
|
US4607028A
(en)
|
1983-08-18 |
1986-08-19 |
Ciba-Geigy Corporation |
Novel carboxylic acid esters
|
|
EP0179583A1
(en)
|
1984-10-04 |
1986-04-30 |
Merck & Co. Inc. |
A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
|
|
US4861765A
(en)
|
1985-06-26 |
1989-08-29 |
Jouveinal |
21-alkyl-, cycloalkyl- or aryl-substituted thio steroids and pharmaceutical compositions containing them
|
|
ZA872389B
(en)
|
1987-04-02 |
1987-11-25 |
Advanced Polymer Systems Inc |
Composition and method for delivering a steroid active ingredient
|
|
US4964069A
(en)
|
1987-05-12 |
1990-10-16 |
International Business Machines Corporation |
Self adjusting video interface
|
|
WO1989003390A1
(en)
|
1987-10-13 |
1989-04-20 |
Bodor Nicholas S |
Soft steroids having anti-inflammatory activity
|
|
US4994439A
(en)
|
1989-01-19 |
1991-02-19 |
California Biotechnology Inc. |
Transmembrane formulations for drug administration
|
|
US5202316A
(en)
*
|
1989-03-22 |
1993-04-13 |
Roussel Uclaf |
N,N,N',N'-6-(1-piperazinyl)-2,5-pyridinediamines
|
|
FR2644788B1
(fr)
|
1989-03-22 |
1995-02-03 |
Roussel Uclaf |
Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
|
JPH07116215B2
(ja)
|
1989-04-19 |
1995-12-13 |
エスエス製薬株式会社 |
新規なステロイド化合物
|
|
JPH04506066A
(ja)
|
1989-06-16 |
1992-10-22 |
ジ・アップジョン・カンパニー |
脈管形成を抑制するためのスラミン・タイプの化合物および脈管形成抑止ステロイド類
|
|
IL95590A
(en)
|
1989-09-08 |
1996-06-18 |
Glaxo Group Ltd |
Medicinal preparations containing Salmetrol and Pluticasone Propionate
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
DE4025342A1
(de)
*
|
1990-08-10 |
1992-02-13 |
Hoechst Ag |
In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
|
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
|
ES2187500T3
(es)
|
1991-02-21 |
2003-06-16 |
Smithkline Beecham Corp |
Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
|
|
GB9103764D0
(en)
|
1991-02-22 |
1991-04-10 |
Glaxo Group Ltd |
Compositions
|
|
US5250293A
(en)
|
1991-04-22 |
1993-10-05 |
Gleich Gerald J |
Method for the treatment of hypersensitivity diseases by administration of anionic polymers
|
|
TW247878B
(enExample)
|
1991-07-02 |
1995-05-21 |
Takeda Pharm Industry Co Ltd |
|
|
US6127353A
(en)
|
1991-09-06 |
2000-10-03 |
Schering Corporation |
Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
|
|
US5658549A
(en)
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
|
NZ263686A
(en)
|
1993-03-17 |
1997-09-22 |
Minnesota Mining & Mfg |
Medicinal aerosol with dispersing aid derived from a hydroxy acid, an amino acid and/or a mercapto acid
|
|
DE4328819A1
(de)
|
1993-08-27 |
1995-03-02 |
Hoechst Ag |
Corticosteroid-17-alkylcarbonat-21/0/-Carbonsäure- und Kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
DE4333920A1
(de)
*
|
1993-10-05 |
1995-04-13 |
Hoechst Ag |
Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
|
|
US5420120A
(en)
|
1993-12-17 |
1995-05-30 |
Alcon Laboratories, Inc. |
Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
|
|
US5837699A
(en)
|
1994-01-27 |
1998-11-17 |
Schering Corporation |
Use of mometasone furoate for treating upper airway passage diseases
|
|
IL109656A
(en)
|
1994-05-15 |
1998-02-22 |
Chemagis Ltd |
Process for the manufacture of androstane - 17 - carbothioates and androstane - 17 - carbothioates prepared thereby
|
|
GB9410222D0
(en)
|
1994-05-21 |
1994-07-06 |
Glaxo Wellcome Australia Ltd |
Medicaments
|
|
GB9419536D0
(en)
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
|
SA95160463B1
(ar)
|
1994-12-22 |
2005-10-04 |
استرا أكتيبولاج |
مساحيق للاستنشاق
|
|
JPH08291072A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
吸入用粉末製剤用結晶とその製造方法
|
|
JPH08291073A
(ja)
|
1995-04-22 |
1996-11-05 |
Kissei Pharmaceut Co Ltd |
医薬品組成物及びその製造方法
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
GB9521696D0
(en)
|
1995-10-23 |
1996-01-03 |
Bayer Ag |
Combination of LTD4 receptor antagonists with glucocorticosteriods
|
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
|
US5792758A
(en)
|
1995-12-08 |
1998-08-11 |
G. D. Searle & Co. |
Steroid nitrite ester derivatives useful as anti-inflammatory drugs
|
|
US5707984A
(en)
|
1995-12-08 |
1998-01-13 |
G. D. Searle & Co. |
Steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
|
|
NZ324373A
(en)
|
1995-12-29 |
1999-10-28 |
Glaxo Group Ltd |
Lactone derivatives of 17-beta-carboxy, carbonyl-thio and amide androstane derivatives
|
|
US5985862A
(en)
|
1996-05-02 |
1999-11-16 |
G.D. Searle & Co. |
Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
|
|
US5981517A
(en)
|
1996-05-09 |
1999-11-09 |
Soft Drugs, Inc. |
Androstene derivatives
|
|
CA2256721A1
(en)
|
1996-06-04 |
1997-12-11 |
The Procter & Gamble Company |
A nasal spray containing an intranasal steroid and an antihistamine
|
|
GB9622173D0
(en)
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
|
US5919776A
(en)
|
1996-12-20 |
1999-07-06 |
Merck & Co., Inc. |
Substituted aminoquinolines as modulators of chemokine receptor activity
|
|
WO1998034598A2
(en)
|
1997-02-07 |
1998-08-13 |
Gist-Brocades B.V. |
Homogeneous granulated formulations for dose sipping technology
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
EP1003501B9
(en)
|
1997-04-02 |
2005-06-08 |
The Brigham And Women's Hospital, Inc. |
Use of an agent for lowering the risk of cardiovascular disease
|
|
AU8439998A
(en)
|
1997-06-30 |
1999-01-25 |
Glaxo Group Limited |
Compounds
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
SE9704833D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New formulation
|
|
US5972920A
(en)
|
1998-02-12 |
1999-10-26 |
Dermalogix Partners, Inc. |
Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
US6136294C1
(en)
|
1998-09-22 |
2002-09-24 |
Aeropharm Technology Inc |
Amino acid stabilized medical aerosol formulation
|
|
US6458338B1
(en)
*
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
|
US6261539B1
(en)
|
1998-12-10 |
2001-07-17 |
Akwete Adjei |
Medicinal aerosol formulation
|
|
EP1055223B1
(en)
*
|
1998-12-17 |
2011-07-13 |
Sony Computer Entertainment Inc. |
Apparatus and method for generating music data
|
|
GB9828721D0
(en)
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
AU3703900A
(en)
|
1999-02-24 |
2000-09-14 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
AU3411000A
(en)
|
1999-03-24 |
2000-10-09 |
Glenayre Electronics, Inc |
Computation and quantization of voiced excitation pulse shapes in linear predictive coding of speech
|
|
HUP0201243A3
(en)
|
1999-04-30 |
2002-11-28 |
Pfizer Prod Inc |
Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
GB9918559D0
(en)
*
|
1999-08-07 |
1999-10-06 |
Glaxo Wellcome Kk |
Novel pharmaceutical formulation
|
|
US20020081266A1
(en)
*
|
1999-08-20 |
2002-06-27 |
Norton Healthcare Ltd. |
Spray dried powders for pulmonary or nasal administration
|
|
WO2001015744A1
(en)
|
1999-08-31 |
2001-03-08 |
The Brigham And Women's Hospital, Inc. |
Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
|
|
AU7703400A
(en)
|
1999-09-14 |
2001-04-17 |
Xenoport, Inc. |
Substrates and screening methods for transport proteins
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
JP2004501067A
(ja)
|
2000-01-28 |
2004-01-15 |
ローム アンド ハース カンパニー |
高められた特性をもつ医薬
|
|
US20020133032A1
(en)
|
2000-02-25 |
2002-09-19 |
Jufang Barkalow |
Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0009591D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medical combinations
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
|
GB0016040D0
(en)
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0017988D0
(en)
|
2000-07-21 |
2000-09-13 |
Glaxo Group Ltd |
Novel process
|
|
US20020037877A1
(en)
|
2000-07-26 |
2002-03-28 |
Alcon Universal Ltd. |
Pharmaceutical suspension compositions lacking a polymeric suspending agent
|
|
SI1305329T2
(sl)
|
2000-08-05 |
2015-07-31 |
Glaxo Group Limited |
S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
|
|
US6787532B2
(en)
*
|
2000-08-05 |
2004-09-07 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivatives
|
|
US6777399B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6750210B2
(en)
|
2000-08-05 |
2004-06-15 |
Smithkline Beecham Corporation |
Formulation containing novel anti-inflammatory androstane derivative
|
|
US6777400B2
(en)
*
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6858593B2
(en)
*
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
AR032362A1
(es)
|
2000-08-14 |
2003-11-05 |
Glaxo Group Ltd |
Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
|
|
NZ525055A
(en)
|
2000-09-29 |
2004-09-24 |
Glaxo Group Ltd |
Compounds useful in the treatment of inflammatory diseases
|
|
AU2002210575A1
(en)
|
2000-10-31 |
2002-05-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel medicament compositions based on anticholinergics and corticosteroids
|
|
DE10062712A1
(de)
|
2000-12-15 |
2002-06-20 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
|
|
CN101518537A
(zh)
|
2000-12-22 |
2009-09-02 |
日本新药株式会社 |
炎症性呼吸道疾病的预防/治疗剂
|
|
US20020132803A1
(en)
|
2001-01-05 |
2002-09-19 |
Mahendra Dedhiya |
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20050070487A1
(en)
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
CA2445839A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
JP2005500290A
(ja)
|
2001-06-12 |
2005-01-06 |
グラクソ グループ リミテッド |
抗炎症性の、１７β−カルボチオアートアンドロスタン誘導体である１７α複素環エステル
|
|
US20030018019A1
(en)
*
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
AU2002321884A1
(en)
|
2001-08-03 |
2003-02-24 |
Smithkline Beecham Corporation |
A method for preparing fluticasone derivatives
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
GB0125259D0
(en)
|
2001-10-20 |
2001-12-12 |
Glaxo Group Ltd |
Novel compounds
|
|
US7399743B2
(en)
|
2001-10-26 |
2008-07-15 |
The Scripps Research Institute |
Targeted thrombosis
|
|
KR20040068544A
(ko)
|
2001-11-05 |
2004-07-31 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
아테롬성 동맥경화증의 예후 표지로서의 가용성 ｃｄ40ｌ(ｃｄ154)
|
|
GB0127160D0
(en)
|
2001-11-12 |
2002-01-02 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2003042229A1
(en)
|
2001-11-12 |
2003-05-22 |
Glaxo Group Limited |
Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids
|
|
AU2002356759A1
(en)
|
2001-12-01 |
2003-06-17 |
Glaxo Group Limited |
17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
|
|
WO2003072592A1
(en)
|
2002-01-15 |
2003-09-04 |
Glaxo Group Limited |
17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
|
|
AU2003201693A1
(en)
|
2002-01-21 |
2003-09-02 |
Glaxo Group Limited |
Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
|
|
GB0202216D0
(en)
|
2002-01-31 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
|
JP3691459B2
(ja)
|
2002-06-14 |
2005-09-07 |
久光メディカル株式会社 |
粉末状吸入剤組成物
|
|
GB0217504D0
(en)
|
2002-07-29 |
2002-09-04 |
Novartis Ag |
Organic compounds
|
|
US7244742B2
(en)
*
|
2002-08-17 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
|